Best Practice (Efficient) Immunohistologic Panel for Diagnosing Metaplastic Breast Carcinoma

Min Han1,2, Huina Zhang1,3, David J Dabbs1,4

  • 1Department of Pathology, University of Pittsburgh Medical Center (UPMC) Magee-Women's Hospital, Pittsburgh, PA.

Summary

Identifying the best immunohistochemistry panel is crucial for diagnosing metaplastic breast carcinomas (MBCs). A combination of OSCAR, cytokeratin 14 (CK14), and p63 antibodies offers the highest diagnostic sensitivity for MBCs.

Related Concept Videos